Latest Insider Transactions at Ovid Therapeutics Inc. (OVID)
This section provides a real-time view of insider transactions for Ovid Therapeutics Inc. (OVID). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ovid Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ovid Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Jeremy M Levin CEO |
BUY
Open market or private purchase
|
Direct |
18,248
+0.5%
|
$36,496
$2.76 P/Share
|
|
Feb 22
2024
|
Jason Tardio Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|
|
Feb 22
2024
|
Thomas Michael Perone General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|
|
Feb 22
2024
|
Jeffrey A Rona CBFO |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|
|
Dec 04
2023
|
Jeremy M Levin CEO |
SELL
Bona fide gift
|
Direct |
1,146,550
-12.91%
|
-
|
|
Sep 12
2022
|
Jason Tardio Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,344
-100.0%
|
$34,688
$2.15 P/Share
|
|
Jul 01
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
5,750,000
+50.0%
|
-
|
|
Jul 01
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,750,000
-100.0%
|
-
|
|
Jul 14
2021
|
Amit Rakhit President and CMO |
SELL
Open market or private sale
|
Direct |
34,017
-4.47%
|
$102,051
$3.71 P/Share
|
|
Jul 14
2021
|
Amit Rakhit President and CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,017
+4.28%
|
$34,017
$1.89 P/Share
|